$3.49 -0.18 (-4.90%)
2/10/2012 3:59 PM

Antigenics, Inc. (NASDAQ:AGEN)

CAPS Rating: 2 out of 5

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

Featured Broker Partners


Advertisement